Literature DB >> 7823160

Calcitonin gene-related peptide: possible role in formation and maintenance of neuromuscular junctions.

C Sala1, J S Andreose, G Fumagalli, T Lømo.   

Abstract

The expression and content of calcitonin gene-related peptide (CGRP) and secretogranin II (SgII) in adult rat motor neurons were examined by in situ hybridization, Northern blot analysis, and immunocytochemistry. Normal motor nerve terminals did not contain detectable CGRP or SgII. Ten to 15 days after a peripheral nerve crush about 80% of the motor nerve terminals reinnervating the soleus (SOL) muscle contained detectable CGRP but no SgII. Thereafter, the percentage of CGRP-positive terminals declined towards zero. In the spinal cord, CGRP expression was higher than normal 1 d after a sciatic nerve crush and increased during the next few days. No increase in SgII expression was observed. Nerve blocks by tetrodotoxin (TTX) and botulinum toxin (BoTX) increased CGRP content and expression in motor neurons but had no effect on SgII. After 10 d of BoTX treatment and 33 d of TTX treatment (the longest time points studied), more than 90% of the motor nerve terminals stained for CGRP. The density of large dense core vesicles (LDCVs) was also higher than normal in such terminals. Some increase in CGRP content and expression occurred in the nontreated side. In a group of rats, the peroneal nerve was stimulated electrically with brief, intermittent pulse trains at 100 Hz. The stimulation was applied below a TTX block that had started 7 or 19 d earlier. One minute of such stimulation was sufficient to remove CGRP from most of the terminals.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7823160      PMCID: PMC6578274     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  21 in total

Review 1.  [Use of botulinum toxin the the treatment of muscle pain].

Authors:  R Benecke; D Dressler; E Kunesch; T Probst
Journal:  Schmerz       Date:  2003-12       Impact factor: 1.107

Review 2.  The role of botulinum toxin in whiplash injuries.

Authors:  Brian Freund; Marvin Schwartz
Journal:  Curr Pain Headache Rep       Date:  2006-10

3.  A prospective randomized double-blinded pilot study to examine the effect of botulinum toxin type A injection versus Lidocaine/Depomedrol injection on residual and phantom limb pain: initial report.

Authors:  Hong Wu; Rizwana Sultana; Kerrey Barton Taylor; Aniko Szabo
Journal:  Clin J Pain       Date:  2012-02       Impact factor: 3.442

4.  Expression of small-conductance calcium-activated potassium channels (SK3) in skeletal muscle: regulation by muscle activity.

Authors:  Morgana Favero; De-Jian Jiang; Christian Chiamulera; Alberto Cangiano; Guido Francesco Fumagalli
Journal:  J Physiol       Date:  2008-08-14       Impact factor: 5.182

5.  Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

Authors:  Y Coulouarn; I Lihrmann; S Jegou; Y Anouar; H Tostivint; J C Beauvillain; J M Conlon; H A Bern; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 6.  The cellular and molecular basis of peripheral nerve regeneration.

Authors:  S Y Fu; T Gordon
Journal:  Mol Neurobiol       Date:  1997 Feb-Apr       Impact factor: 5.590

7.  Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS.

Authors:  Emiliano Trias; Sofía Ibarburu; Romina Barreto-Núñez; Valentina Varela; Ivan C Moura; Patrice Dubreuil; Olivier Hermine; Joseph S Beckman; Luis Barbeito
Journal:  JCI Insight       Date:  2017-10-19

8.  Disruption of calcitonin gene-related peptide signaling accelerates muscle denervation and dampens cytotoxic neuroinflammation in SOD1 mutant mice.

Authors:  Cornelia Ringer; Sarah Tune; Mirjam A Bertoune; Hans Schwarzbach; Kazutake Tsujikawa; Eberhard Weihe; Burkhard Schütz
Journal:  Cell Mol Life Sci       Date:  2016-08-23       Impact factor: 9.261

9.  On the possible origin of giant or slow-rising miniature end-plate potentials at the neuromuscular junction.

Authors:  L C Sellin; J Molgó; K Törnquist; B Hansson; S Thesleff
Journal:  Pflugers Arch       Date:  1996-01       Impact factor: 3.657

10.  Sustained CGRP1 receptor stimulation modulates development of EC coupling by cAMP/PKA signalling pathway in mouse skeletal myotubes.

Authors:  Guillermo Avila; Citlalli I Aguilar; Roberto Ramos-Mondragón
Journal:  J Physiol       Date:  2007-07-26       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.